[EN] COMPOUNDS FOR THE TREATMENT OF HIV<br/>[FR] COMPOSÉS POUR TRAITER LE VIH
申请人:GILEAD SCIENCES INC
公开号:WO2013006738A1
公开(公告)日:2013-01-10
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
The compounds of the invention are compounds represented by the following general formula (1):
1
wherein E represents one selected from the group consisting of a methylidyne group and a nitrilo group, R
1
represents one selected from the group consisting of optionally substituted aryl groups and optionally substituted heteroaryl groups, R
2
represents one selected from the group consisting of a hydrogen atom and alkyl groups, W
1
represents an amino acid residue, A represents one selected from the group consisting of a carbonyl group and a sulfonyl group, X
1
represents one selected from the group consisting of optionally substituted alkylene groups and optionally substituted alkenylene groups, and p represents 0 or 1;
and their pharmacologically acceptable salts, which exhibit thrombopoietin-like activity.
biological activities of these compounds were compared by three bioassays with those of indole-3-acetic acid and 4-chloroindole-3-acetic acid (4-Cl-IAA), which, like 4-CF(3)-IAA and 4-CH(3)-IAA, has a substituent at the 4-position of the indole nucleus. 4-CF(3)-IAA showed strong root formation-promoting activity with black gram cuttings which was 1.5 times higher than that of 4-(3-indole)butyric acid at 1x10(-4)